Showing Results for: “diabetes exercise”

On May 22, 2019, Colorado Governor Jared Polis signed the first bill in the nation that will cap insulin co-pays at $100 per month, regardless of the number of vials needed. House Bill 1216: Reduce Insulin Prices, also enlists the Colorado Attorney General to investigate the rising price of insulin in Colorado and make recommendations to the General Assembly for further action. The American Diabetes Association (ADA) applauds Governor Polis and bill sponsors, Representative Dylan Roberts and Senators Kerry Donovan and Kevin Priola, for their leadership on this important legislation to reduce

The American Diabetes Association® (ADA) will present the 2019 Outstanding Scientific Achievement Award (OSAA) to Sadaf Farooqi, MB, ChB (Hons), PhD. Dr. Farooqi will be recognized with this honor, which is given annually for research in diabetes that demonstrates particular independence of thought and originality, during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. She will deliver her OSAA Lecture, titled “ Obesity and the Biology of Weight Regulation ,” during the National Scientific and Health Care Achievement Awards Presentation

Initial data indicate that children presented with higher acuity compared to the previous year New data show that the incidence and acuity of type 2 diabetes in children increased significantly during the peak of the COVID-19 pandemic, with more pediatric patients hospitalized from March to December 2020 compared to the same time period in 2019. Findings from the retrospective chart review were presented as a late-breaking poster session at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Stay-at-home orders due to the COVID-19 pandemic exacerbated risk

Texas becomes 19th state to sign vital legislation to help insulin costs for those with diabetes Today, the American Diabetes Association ® (ADA) applauded a major victory secured for people with diabetes in Texas as Governor Greg Abbott signed legislation yesterday that will help make insulin more affordable for Texans on state-regulated health plans. The new law, created by Senate Bill 827 and supported by the ADA, limits cost-sharing to $25 per prescription for a 30-day supply of insulin, regardless of the amount or type of insulin needed. With the signing of this bill, Texas becomes the

Reduced hospitalization rates among people with low self-monitoring of blood glucose (SMBG) are especially pronounced People using Abbott’s FreeStyle Libre, a sensor-based glucose monitoring system, experienced a considerable decrease in ketoacidosis-related hospitalizations—52% for type 1 diabetes and 47% for type 2 diabetes—according to the study titled “Dramatic Drop in Ketoacidosis Rate after FreeStyle Libre System Initiation in Type 1 and Type 2 Diabetes in France, Especially in People with Low Self-Monitoring of Blood Glucose (SMBG): A Nationwide Study,” presented today at the American

American Diabetes Association ® partners with Abbott to donate 25,000 CGM sensors to hospitals across the country Recently, the Food and Drug Administration (FDA) issued guidance to expand the availability and capability of non-invasive remote monitoring devices during the COVID-19 pandemic. This change was made in an effort to improve the ability of health care providers to monitor their patients while reducing their exposure to the novel coronavirus. The new policy will apply to non-invasive patient monitoring technology, including continuous glucose monitors (CGM), and expands their

New legislation in Illinois to make insulin more affordable for all Illinoisans who need it Today, Illinois Governor J.B. Pritzker signed legislation that will cap insulin co-pays. Senate Bill 667 (SB 667) also requires the Illinois Department of Insurance to issue a report that includes a summary of insulin pricing practices as well as public policy recommendations to control and prevent overpricing of prescription insulin drugs made available to Illinois consumers. The American Diabetes Association (ADA) applauds Governor Pritzker and bill sponsors Senator Andy Manar and Representative Will

Novel Weight Loss Drug, Survodutide, Shows Significant Weight Loss of Nearly 19% At 46 Weeks Oral Semaglutide Demonstrates Weight Loss Up to 15% for People with Obesity and Improved Management of Type 2 Diabetes Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Association’s ® (ADA) 83rd Scientific Sessions in San Diego, CA. Two of the studies were also simultaneously published in The Lancet . This comes at a time when more than 37 million Americans live with diabetes, and nearly 90% of people with diabetes are overweight or

Stem Cell-Derived Fully Differentiated Islet Cells Shown to Restore Endogenous Insulin Secretion and Improved Glycemic Control in People Living with Type 1 Diabetes Today, findings from the ongoing clinical trial of VX-880, a phase 1/2, multi-center, single-arm, open-label study in patients with type 1 diabetes (T1D) were presented, demonstrating the potential of stem cell-derived islet cell therapy as a future treatment option for patients with T1D. All patients treated with VX-880 had undetectable insulin secretion and a history of recurrent severe hypoglycemic events (SHE) in the year prior

A federal court has approved a landmark settlement that will ensure children with diabetes in New York City receive the care they need to fully participate in school and school-related activities. This class action settlement resolves claims that New York City, the Department of Education, the Department of Health and Mental Hygiene, and the Office of School Health systemically failed to ensure that students with diabetes could attend school safely and have access to the same educational opportunities as their peers, in violation of the Americans with Disabilities Act (“ADA”), Section 504 of